Methods
• At the scoping stage, the list of health state utility values to be captured was identified by reviewing the list of microvascular and macrovascular complications associated with T2DM and commonly used within existing models. • Articles were included if they reported a cohort study performed in adults reporting the effect of T2DM complications on utility values. Exclusion criteria included non -English publications, paediatric population, instruments without conversion to utility measure or the effect of a specific therapies on utility values.
• When articles presenting EQ -5D index data were available for a given complication, only these articles were included in the relevance assessment.
• A set of utility values was selected following the relevance and quality assessment.
The use of values generated using a multiple regression was preferred over use of the unadjusted data. Given the high number of T2DM complications homogeneity of the estimates was considered important. 
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Objective
• Type 2 diabetes mellitus (T2DM) represents a major public health burden. Consequently, several T2DM treatments will be submitted to health technology assessment agencies for reimbursement over the next years and assessed according to their relative cost -effectiveness.
• The NICE reference case for the measurement and valuation of health for use in cost -effectiveness models emphases the QALY as the preferred measure of the benefit (1, 4). EQ -5D has been shown to be valid, reliable and responsive in T2DM (2). Other NICE preferences include: patient reported outcomes, tariffs elicited with the general population, UK setting.
• The reference case states that the quality and the relevance of the studies should be assessed following the same principles as that for clinical effectiveness reviews, however there are currently no agreed reporting standards to justify the selection of a set of relevant utility values.
• The aim of this systematic literature review was to provide a set of utility values associated with T2DM -related complications in line with NICE reference case to be used in modelling studies. 
